Main Menu

Supporting Research. Empowering Families.

Share This

research

No Stomach For Cancer is dedicated to supporting innovative programs to further the understanding of stomach cancer, improve detection, treatment options, survival rates, and quality of life for stomach cancer patients through direct funding of stomach cancer research programs.

Grant Opportunities

No Stomach For Cancer is proud to be able to fund research that is essential in leading to a cure for stomach cancer and offers funding to support promising stomach cancer research projects worldwide. We have chosen the most promising proposals to apply for our grant, and our in the process of our final reviews for this grant cycle.

Join our email list to be informed of future research funding opportunities.

Sign up for our newsletter and stay informed.

Sign Up Now

Or text NOSTOMACH4CANCER to 22828 to join our email list.

Grants Awarded

July 2017

Recipient: Peter MacCallum Cancer Centre
Project: Using a blood biomarker PredictR to predict early recurrence of Gastric Cancer
Principal Investigators: Alex Boussioutas, MBBS, Ph.D., FRACP, Dr. Rita Busuttil
Funding: $50,000

Press Release

June 2017

Recipient: Dana-Farber Cancer Institute
Project: Enhancing Immunotherapy for Gastric Cancer
Principal Investigators: Dr. Adam Bass, Leonie DeKlerk, Dr. Yang Liu
Funding: $50,000

Press Release

May 2015, August 2017

Recipient: Institute of Molecular Pathology and Immunology of the University of Porto, Portugal (IPATIMUP)
Project: Today’s present, tomorrow’s future on the study of germline E-cadherin missense mutations. 

When an individual is tested for a gene mutation relating to stomach cancer, the results are not always conclusive.  The Institute provides a service that further analyzes these tests to obtain a more definitive answer regarding germline E - cadherin gene mutations.   No Stomach For Cancer has provided funding for this vital project since 2015 - helping these individuals to receive more accurate testing results to make the best choices for their future.


Principal Investigators: Raquel Seruca MD Ph.D., IPATIMUP, Joana Peredes Ph.D., IPATIMUP, and Joao Sanches Ph.D., Institute for Systems and Robotics, LARSys, Instituto Superior Tecnico, University of Lisbon, Portugal
Funding: $60,000

Read The Project Update | Press Release

Read the Publication

July 15, 2014

Recipient: University of British Columbia, Vancouver, British Columbia, Canada
Project: Defining the contribution of mutations in CDH1 non-coding regions and other known susceptibility genes to hereditary gastric cancer
Principal Investigators: Dr. David Huntsman, BC Cancer Agency, Vancouver British Columbia, Canada and Dr. Carla Oliveira, IPATIMUP, University of Porto, Porto, Portugal. Collaboration and Partnership with the International Gastric Cancer Linkage Consortium (IGCLC).
Funding: $50,000

Read the press release

Read the Publication

 

July 15, 2014

Recipient: University of California, Davis
Project: Gastric cancer gene identification through haplotype analysis and sequencing
Principal Investigator: Dr. Luis Carvajal Carmona, UC Davis Genome Center, Davis, California
Funding: $50,000

Read the press release

Read the Publication

 

May 16, 2013

Recipient: Centre for Translational Cancer Research, University of Otago, Dunedin, NZ
Project: The identification of new drugs for the treatment and prevention of diffuse gastric cancer using high throughput compound screening approach
Principal Investigator: Dr. Parry Guilford, University of Otago, Dunedin, New Zealand
Funding: $20,000

Read the Project Plan

Read the Project Update

Read the Publication

December 26, 2012

Recipient: Centre for Translational Cancer Research, University of Otago, Dunedin, NZ
Project: Genetic Predisposition to Gastric Cancer
An open-ended project, with a commitment to incremental funding dependent upon progress and developments.
Principal Investigator: Dr. Parry Guilford, University of Otago, Dunedin, New Zealand
Funding: $10,000

Read the information sheet